Alchem International announced that it will continue to market and support Tropane Alkaloid APIs despite earlier reports.
Alchem International confirmed on Sept. 15, 2014 that it will not end market development and regulatory support of Tropane Alkaloid APIs, but will maintain production and regulatory (drug master file) support from its GMP production units.
"Whilst the tropane alkaloid family of APIs is a specialist business and difficult to manage within larger scale production facilities, Alchem International has invested in a suite of bespoke manufacturing and regulatory capabilities to support smaller-scale, as well as, large-scale API production and dossier support,” said Raman Mehta, CEO and president at Alchem International, in a press release.
Alchem International will be present at CPhI Worldwide 2014 in Paris located at booth 6T55.
